77857
酮还原酶
recombinant, expressed in E. coli, ≥0.2 U/mg
登录 查看组织和合同定价。
选择尺寸
关于此项目
化学文摘社编号:
UNSPSC Code:
12352204
EC Number:
232-823-8
MDL number:
Specific activity:
≥0.2 U/mg
Recombinant:
expressed in E. coli
recombinant
expressed in E. coli
form
powder
specific activity
≥0.2 U/mg
storage temp.
2-8°C
Application
酮还原酶可用于研究酮还原酶结构域的立体特异性 。它们可用于对α-氯醇的前体进行还原，该前体是多种药物化合物的合成中间体 。
Biochem/physiol Actions
酮还原酶（产品77857）以NADPH作为共底物还原4-氯乙酰乙酸酯。
Packaging
无底玻璃瓶。内含物在插入的融合锥体内。
Other Notes
1U 相当于在 pH 6.0，25°C 下每分钟还原 1 μmol 4-氯乙酰乙酸所需的酶量（共底物NADPH）。
signalword
Danger
hcodes
Hazard Classifications
Resp. Sens. 1 - Skin Sens. 1
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
常规特殊物品
此项目有
Roselyne Castonguay et al.
Journal of the American Chemical Society, 130(35), 11598-11599 (2008-08-13)
Tylactone synthase (TYLS) is a modular polyketide synthase that catalyzes the formation of tylactone (1), the parent aglycone precursor of the macrolide antibiotic tylosin. TYLS modules 1 and 2 are responsible for the generation of antidiketide and triketide intermediates, respectively
Automation Highlights from the Literature
Kerstin Thurow and Hilmar Weinmann
Journal of Laboratory Automation, 11, 1-6 (2006)
Q Ye et al.
Proteins, 44(1), 12-19 (2001-05-17)
Pig aldehyde reductase containing the active site mutation tyrosine(50) to phenylalanine has been crystallized in the presence of the cofactor NADP(H) to a resolution of 2.2 A. This structure clearly shows loss of the tyrosine hydroxyl group and no other
Kazumasa Takenaka et al.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 14(8), 1972-1975 (2005-08-17)
Carbonyl reductase (CBR) is a cytosolic NADPH-dependent oxidoreductase metabolizing prostaglandins, steroids, quinines, and anthracycline antibiotics. Many experimental studies have shown that CBR plays important roles in the regulation of tumor progression, but clinical significance of CBR status remains unclear. Thus
Ossama El-Kabbani et al.
Journal of medicinal chemistry, 48(17), 5536-5542 (2005-08-19)
Structure determination of porcine aldehyde reductase holoenzyme in complex with the potent aldose reductase inhibitor fidarestat was carried out to explain the difference in the potency of the inhibitor for aldose and aldehyde reductases. The hydrogen bonds between the active-site
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持